tiprankstipranks
Trending News
More News >
CVS Health Corp (CVS)
NYSE:CVS
US Market

CVS Health (CVS) Ratios

Compare
13,533 Followers

CVS Health Ratios

CVS's free cash flow for Q4 2024 was $0.13. For the 2024 fiscal year, CVS's free cash flow was decreased by $ and operating cash flow was $0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.81 0.86 0.95 0.88 0.91
Quick Ratio
0.60 0.63 0.67 0.62 0.61
Cash Ratio
0.10 0.10 0.19 0.14 0.13
Solvency Ratio
0.05 0.07 0.05 0.08 0.07
Operating Cash Flow Ratio
0.11 0.17 0.23 0.27 0.26
Short-Term Operating Cash Flow Coverage
1.22 4.52 9.10 4.34 2.92
Net Current Asset Value
$ -108.84B$ -105.23B$ -90.87B$ -97.61B$ -104.64B
Leverage Ratios
Debt-to-Assets Ratio
0.33 0.32 0.31 0.33 0.37
Debt-to-Equity Ratio
1.10 1.04 0.99 1.01 1.23
Debt-to-Capital Ratio
0.52 0.51 0.50 0.50 0.55
Long-Term Debt-to-Capital Ratio
0.50 0.43 0.41 0.41 0.46
Financial Leverage Ratio
3.35 3.27 3.19 3.10 3.32
Debt Service Coverage Ratio
1.16 2.73 2.67 2.23 1.74
Interest Coverage Ratio
2.88 5.17 3.48 5.32 4.79
Debt to Market Cap
1.47 0.61 0.43 0.41 0.72
Interest Debt Per Share
68.21 63.85 55.65 59.52 67.19
Net Debt to EBITDA
5.42 3.91 4.68 3.80 4.51
Profitability Margins
Gross Profit Margin
13.79%15.21%16.90%17.84%18.25%
EBIT Margin
2.44%3.87%2.52%4.46%4.72%
EBITDA Margin
3.68%5.09%3.83%6.00%6.37%
Operating Profit Margin
2.28%3.84%2.47%4.56%5.18%
Pretax Profit Margin
1.65%3.12%1.81%3.61%3.64%
Net Profit Margin
1.24%2.33%1.34%2.74%2.67%
Continuous Operations Profit Margin
1.23%2.34%1.34%2.73%2.68%
Net Income Per EBT
75.05%74.68%73.87%75.93%73.48%
EBT Per EBIT
72.19%81.30%73.37%79.17%70.23%
Return on Assets (ROA)
1.82%3.34%1.89%3.43%3.11%
Return on Equity (ROE)
6.11%10.91%6.03%10.66%10.35%
Return on Capital Employed (ROCE)
5.05%8.06%5.01%8.06%8.25%
Return on Invested Capital (ROIC)
3.61%5.87%3.63%5.90%5.83%
Return on Tangible Assets
3.43%6.46%3.44%6.41%5.98%
Earnings Yield
8.16%8.22%3.53%5.88%8.03%
Efficiency Ratios
Receivables Turnover
10.22 10.16 11.82 11.96 12.36
Payables Turnover
20.22 20.36 18.06 19.13 19.72
Inventory Turnover
17.75 16.83 14.04 13.51 11.88
Fixed Asset Turnover
12.88 11.76 10.49 9.12 8.06
Asset Turnover
1.47 1.43 1.41 1.25 1.16
Working Capital Turnover Ratio
-27.32 -47.33 -55.66 -43.45 -62.14
Cash Conversion Cycle
38.22 39.70 36.67 38.46 41.76
Days of Sales Outstanding
35.71 35.94 30.87 30.53 29.53
Days of Inventory Outstanding
20.56 21.69 26.00 27.01 30.73
Days of Payables Outstanding
18.05 17.92 20.21 19.08 18.51
Operating Cycle
56.27 57.63 56.88 57.54 60.27
Cash Flow Ratios
Operating Cash Flow Per Share
7.23 10.45 12.33 13.85 12.12
Free Cash Flow Per Share
5.02 8.09 10.25 11.94 10.26
CapEx Per Share
2.21 2.36 2.08 1.91 1.86
Free Cash Flow to Operating Cash Flow
0.69 0.77 0.83 0.86 0.85
Dividend Paid and CapEx Coverage Ratio
1.48 2.18 2.87 3.55 3.13
Capital Expenditure Coverage Ratio
3.27 4.43 5.93 7.25 6.51
Operating Cash Flow Coverage Ratio
0.11 0.17 0.23 0.24 0.19
Operating Cash Flow to Sales Ratio
0.02 0.04 0.05 0.06 0.06
Free Cash Flow Yield
11.19%10.25%11.00%11.57%15.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.25 12.16 28.36 17.01 12.45
Price-to-Sales (P/S) Ratio
0.15 0.28 0.38 0.47 0.33
Price-to-Book (P/B) Ratio
0.75 1.33 1.71 1.81 1.29
Price-to-Free Cash Flow (P/FCF) Ratio
8.93 9.76 9.09 8.64 6.66
Price-to-Operating Cash Flow Ratio
6.21 7.56 7.56 7.45 5.64
Price-to-Earnings Growth (PEG) Ratio
-0.28 0.13 -0.63 1.79 1.67
Price-to-Fair Value
0.75 1.33 1.71 1.81 1.29
Enterprise Value Multiple
9.55 9.49 14.58 11.56 9.73
EV to EBITDA
9.55 9.49 14.58 11.56 9.73
EV to Sales
0.35 0.48 0.56 0.69 0.62
EV to Free Cash Flow
20.68 16.61 13.39 12.87 12.41
EV to Operating Cash Flow
14.37 12.86 11.13 11.10 10.50
Tangible Book Value Per Share
-34.05 -34.14 -23.77 -24.84 -31.32
Shareholders’ Equity Per Share
60.02 59.50 54.47 56.92 53.01
Tax and Other Ratios
Effective Tax Rate
0.25 0.25 0.26 0.24 0.26
Revenue Per Share
296.12 278.42 245.78 221.46 205.28
Net Income Per Share
3.66 6.49 3.29 6.07 5.48
Tax Burden
0.75 0.75 0.74 0.76 0.73
Interest Burden
0.68 0.81 0.72 0.81 0.77
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 <0.01 <0.01 <0.01 <0.01
Income Quality
1.99 1.60 3.74 2.29 2.21
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis